pimozide has been researched along with Leukemia, Prolymphocytic, T-Cell in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bailey, NG; Betz, BL; Chung, F; Elenitoba-Johnson, KS; Herling, M; Kiel, MJ; Li, B; Li, JZ; Lim, MS; Medeiros, LJ; Miranda, RN; Ozel, AB; Rolland, D; Sahasrabuddhe, AA; Schrader, A; Velusamy, T; Zhao, L | 1 |
1 other study(ies) available for pimozide and Leukemia, Prolymphocytic, T-Cell
| Article | Year |
|---|---|
Integrated genomic sequencing reveals mutational landscape of T-cell prolymphocytic leukemia.
Topics: Adult; Aged; Aged, 80 and over; Amino Acid Sequence; Ataxia Telangiectasia Mutated Proteins; Base Sequence; Cell Death; Cohort Studies; Computer Simulation; DNA Copy Number Variations; DNA Mutational Analysis; DNA, Neoplasm; Exome; Female; Humans; Interleukin Receptor Common gamma Subunit; Janus Kinase 1; Janus Kinase 3; Leukemia, Prolymphocytic, T-Cell; Male; Middle Aged; Models, Molecular; Molecular Sequence Data; Mutation; Pimozide; Protein Conformation; Sequence Analysis, DNA; Sequence Homology, Amino Acid; STAT5 Transcription Factor; Tumor Cells, Cultured | 2014 |